CA2194397A1 - Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyrique inhibiteur d'adhesion cellulaire - Google Patents
Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyrique inhibiteur d'adhesion cellulaireInfo
- Publication number
- CA2194397A1 CA2194397A1 CA002194397A CA2194397A CA2194397A1 CA 2194397 A1 CA2194397 A1 CA 2194397A1 CA 002194397 A CA002194397 A CA 002194397A CA 2194397 A CA2194397 A CA 2194397A CA 2194397 A1 CA2194397 A1 CA 2194397A1
- Authority
- CA
- Canada
- Prior art keywords
- optically active
- pharmaceutically
- ester
- active compound
- amide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
La présente invention se rapporte à l'acide (-)-(3R)-3-méthyl-4-{4-[4-(4-pyridyl)pipérazin-1-yl]phénoxy}butyrique, nouveau composé doté d'une activité optique, ainsi qu'à ses sels, esters, amides, ou solvates pharmaceutiquement acceptables. Cette invention concerne également des procédés de préparation de ce composé, des compositions pharmaceutiques contenant ce composé et l'utilisation de ce composé comme inhibiteur de l'adhésion cellulaire, et notamment de l'agrégation plaquettaire.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/457,538 US5652242A (en) | 1993-03-29 | 1995-06-01 | Heterocyclic derivatives |
| US08/457538 | 1995-06-01 | ||
| GB9518188.9 | 1995-09-07 | ||
| GBGB9518188.9A GB9518188D0 (en) | 1995-09-07 | 1995-09-07 | Optically active derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2194397A1 true CA2194397A1 (fr) | 1996-12-05 |
Family
ID=26307696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002194397A Abandoned CA2194397A1 (fr) | 1995-06-01 | 1996-05-28 | Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyrique inhibiteur d'adhesion cellulaire |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP0796247A1 (fr) |
| JP (1) | JP2885941B2 (fr) |
| KR (1) | KR100245957B1 (fr) |
| AT (1) | AT406675B (fr) |
| AU (1) | AU710105B2 (fr) |
| BE (1) | BE1009520A5 (fr) |
| BR (1) | BR9606409A (fr) |
| CA (1) | CA2194397A1 (fr) |
| CH (1) | CH691808A5 (fr) |
| CZ (1) | CZ26997A3 (fr) |
| DE (1) | DE19680509T1 (fr) |
| DK (1) | DK10697A (fr) |
| ES (1) | ES2137886B1 (fr) |
| FI (1) | FI970393A (fr) |
| GB (1) | GB2304340B (fr) |
| GR (1) | GR1002702B (fr) |
| HU (1) | HUP9700274A3 (fr) |
| IE (1) | IE960405A1 (fr) |
| IL (1) | IL118477A0 (fr) |
| IT (1) | IT1290839B1 (fr) |
| LU (1) | LU90008B1 (fr) |
| MC (1) | MC2418A1 (fr) |
| MX (1) | MX9700379A (fr) |
| NL (1) | NL1003243C2 (fr) |
| NO (1) | NO307460B1 (fr) |
| NZ (1) | NZ308597A (fr) |
| PL (1) | PL318440A1 (fr) |
| SE (1) | SE510812C2 (fr) |
| SK (1) | SK13097A3 (fr) |
| TR (1) | TR199700020T1 (fr) |
| WO (1) | WO1996038416A1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0100158A3 (fr) * | 1982-07-28 | 1985-03-27 | The Upjohn Company | Hétéroalkysylalkanoles 3-pyridinyliques, leurs acides alkanoiques et leurs esters |
| GB8609630D0 (en) * | 1986-04-19 | 1986-05-21 | Pfizer Ltd | Anti-arrhythmia agents |
| DK0825184T3 (da) * | 1993-03-29 | 2001-09-10 | Astrazeneca Ab | Heterocykliske derivater som blodpladeaggregeringsinhibitorer |
| IL109145A0 (en) * | 1993-03-29 | 1994-06-24 | Zeneca Ltd | Heterocyclic compounds |
-
1996
- 1996-05-28 TR TR97/00020T patent/TR199700020T1/xx unknown
- 1996-05-28 HU HU9700274A patent/HUP9700274A3/hu unknown
- 1996-05-28 EP EP96919906A patent/EP0796247A1/fr not_active Withdrawn
- 1996-05-28 MX MX9700379A patent/MX9700379A/es unknown
- 1996-05-28 SK SK130-97A patent/SK13097A3/sk unknown
- 1996-05-28 CH CH00224/97A patent/CH691808A5/de not_active IP Right Cessation
- 1996-05-28 AT AT0900596A patent/AT406675B/de active
- 1996-05-28 AU AU58272/96A patent/AU710105B2/en not_active Ceased
- 1996-05-28 BR BR9606409A patent/BR9606409A/pt not_active Application Discontinuation
- 1996-05-28 JP JP8536281A patent/JP2885941B2/ja not_active Expired - Fee Related
- 1996-05-28 PL PL96318440A patent/PL318440A1/xx unknown
- 1996-05-28 CA CA002194397A patent/CA2194397A1/fr not_active Abandoned
- 1996-05-28 GR GR960100176A patent/GR1002702B/el not_active IP Right Cessation
- 1996-05-28 DE DE19680509T patent/DE19680509T1/de not_active Withdrawn
- 1996-05-28 ES ES009750006A patent/ES2137886B1/es not_active Expired - Fee Related
- 1996-05-28 CZ CZ97269A patent/CZ26997A3/cs unknown
- 1996-05-28 NZ NZ308597A patent/NZ308597A/en unknown
- 1996-05-28 WO PCT/GB1996/001260 patent/WO1996038416A1/fr not_active IP Right Cessation
- 1996-05-28 GB GB9627127A patent/GB2304340B/en not_active Expired - Fee Related
- 1996-05-28 KR KR1019970700532A patent/KR100245957B1/ko not_active IP Right Cessation
- 1996-05-29 MC MC2347A patent/MC2418A1/fr unknown
- 1996-05-30 IL IL11847796A patent/IL118477A0/xx unknown
- 1996-05-31 NL NL1003243A patent/NL1003243C2/xx not_active IP Right Cessation
- 1996-05-31 BE BE9600491A patent/BE1009520A5/fr not_active IP Right Cessation
- 1996-05-31 IE IE960405A patent/IE960405A1/en not_active IP Right Cessation
- 1996-05-31 IT IT96MI001113A patent/IT1290839B1/it active IP Right Grant
-
1997
- 1997-01-22 LU LU90008A patent/LU90008B1/fr active
- 1997-01-24 SE SE9700203A patent/SE510812C2/sv not_active IP Right Cessation
- 1997-01-30 DK DK010697A patent/DK10697A/da not_active Application Discontinuation
- 1997-01-30 FI FI970393A patent/FI970393A/fi unknown
- 1997-01-31 NO NO970437A patent/NO307460B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0478328B1 (fr) | Antagonistes de récepteur du fibrinogène | |
| AU698705B2 (en) | Thrombin inhibitors | |
| CA2390231A1 (fr) | Inhibiteurs de la dipeptidyl peptidase iv; methodes de fabrication et d'utilisation desdits inhibiteurs | |
| SK63194A3 (en) | Peptide derivatives | |
| WO1992016549A1 (fr) | Derives de phenylalanine substitues en position para | |
| CA2268621A1 (fr) | Derive d'acide 2-pipirazinone-1-acetique, production et utilisation de celui-ci | |
| JPH01503063A (ja) | 抗炎症組成物 | |
| US11434198B2 (en) | Compounds and methods for the treatment of neurodegenerative diseases | |
| JPH072820A (ja) | 不可逆ヒト免疫不全ウイルス（ｈｉｖ）プロテアーゼ阻害剤、その中間体、組成物およびその製法 | |
| CA2022112A1 (fr) | Certains composes d'imidazole comme inhibiteurs de la transglutaminase | |
| CN101790528A (zh) | 氨基酰基前药 | |
| FR2758329A1 (fr) | Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique | |
| CA2070983A1 (fr) | Inhibiteurs cycliques de la renine | |
| CA2194397A1 (fr) | Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyrique inhibiteur d'adhesion cellulaire | |
| SK281025B6 (sk) | (1-fenyl-1-heterocyklyl)alkánové deriváty, spôsoby ich prípravy, medziprodukty na ich prípravu, farmaceutické prostriedky s ich obsahom a ich použitie | |
| JPH10175967A (ja) | 新規なｎ−ベンジルピペラジン化合物、その製造法及びそれを含有する医薬組成物 | |
| HU205951B (en) | Process for producing amino-acid derivatives and pharmaceutical compositions containing them | |
| CA2887420A1 (fr) | Inhibiteurs de metalloproteinases matricielles et methodes de traitement de la douleur et d'autres maladies | |
| NZ306451A (en) | Substituted phenyl amidines, medicaments containing these compounds and process for producing them | |
| CN102924567B (zh) | 一类肽化合物、其制备方法及用途 | |
| CA2022110A1 (fr) | Composes d'azole et leur utilisation comme inhibiteurs de la transglutaminase | |
| CA2230445C (fr) | Antagonistes de recepteur de fibrinogene, et preparation medicinale contenant ces antagonistes en tant qu'ingredient actif | |
| US5817680A (en) | Hemoregulatory compounds | |
| CH677610A5 (fr) | ||
| FR2734818A1 (fr) | Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazine-1-yl- phenoxy}-butyrique, procede pour sa preparation et composition pharmaceutique le contenant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |